Fellowship · La Jolla, CA
Sponsored by University of California (San Diego) Medical Center
Suzetrigine, a Nonopioid Na V 1.8 Inhibitor for Treatment of Moderate-to-severe Acute Pain: Two Phase 3 Randomized Clinical Trials.
Anesthesiology · 2025 · 106 citations · Jessica Oswald
AI-Generated Draft Replies Integrated Into Health Records and Physicians' Electronic Communication.
JAMA network open · 2024 · 100 citations · Gregory Polston
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 71 citations · Mark Wallace
Suzetrigine, a Non-Opioid NaV1.8 Inhibitor With Broad Applicability for Moderate-to-Severe Acute Pain: A Phase 3 Single-Arm Study for Surgical or Non-Surgical Acute Pain.
Journal of pain research · 2025 · 47 citations · Jessica Oswald
ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids.
Regional anesthesia and pain medicine · 2023 · 70 citations · Mark Wallace
Consensus practice guidelines on interventions for cervical spine (facet) joint pain from a multispecialty international working group.
Regional anesthesia and pain medicine · 2022 · 94 citations ·
Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials.
Pain · 2021 · 160 citations · Mark Wallace
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Cancer discovery · 2023 · 146 citations · Yujie Ding